Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

GL Sciences stock

7705.T
JP3385850007

Price

2,817.00
Today +/-
+0
Today %
+0 %

GL Sciences stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the GL Sciences stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the GL Sciences stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the GL Sciences stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze GL Sciences's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

GL Sciences Stock Price History

DateGL Sciences Price
11/12/20242,817.00 undefined
11/11/20242,746.00 undefined

GL Sciences Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into GL Sciences, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by GL Sciences from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects GL Sciences’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of GL Sciences. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into GL Sciences’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing GL Sciences’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on GL Sciences’s growth potential.

GL Sciences Revenue, EBIT and net profit per share

DateGL Sciences RevenueGL Sciences EBITGL Sciences Net Income
202437.15 B undefined5.71 B undefined3.43 B undefined
202338.68 B undefined6.03 B undefined3.5 B undefined
202233.12 B undefined4.81 B undefined2.8 B undefined
202129.22 B undefined3.85 B undefined2.26 B undefined
202025.53 B undefined2.72 B undefined1.63 B undefined
201924.8 B undefined2.99 B undefined2.01 B undefined
201822.94 B undefined2.42 B undefined1.75 B undefined
201720.58 B undefined1.8 B undefined1.32 B undefined
201618.5 B undefined955.06 M undefined773.86 M undefined
201518.14 B undefined887.52 M undefined632.73 M undefined
201418.58 B undefined1.32 B undefined777 M undefined
201316.74 B undefined1.05 B undefined526 M undefined
201216.51 B undefined945 M undefined610 M undefined
201116.22 B undefined738 M undefined372 M undefined
201015.68 B undefined279 M undefined191 M undefined
200916.32 B undefined49 M undefined-152 M undefined
200818.54 B undefined805 M undefined572 M undefined
200718.98 B undefined1.2 B undefined592 M undefined
200616.79 B undefined1.13 B undefined990 M undefined
200516.66 B undefined1.07 B undefined466 M undefined

GL Sciences Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
15.3413.9413.9616.414.2115.4116.0816.6616.7918.9818.5416.3215.6816.2216.5116.7418.5818.1418.520.5822.9424.825.5329.2233.1238.6837.15
--9.130.1117.48-13.368.454.363.590.7813.04-2.31-11.94-3.953.431.801.4010.99-2.341.9611.2611.458.122.9414.4413.3616.79-3.96
40.6737.2933.7539.7532.9229.4330.1832.2232.4130.3929.3128.9531.0933.0733.1735.3536.0733.3232.9135.0335.5535.3033.3533.4733.9134.6736.31
6.245.24.716.524.684.534.855.375.445.775.434.734.885.365.485.926.76.056.097.218.158.768.519.7811.2313.4113.49
1.010.732.011.141.260.070.490.470.990.590.57-0.150.190.370.610.530.780.630.771.321.752.011.632.262.83.53.43
--27.51174.79-43.3210.99-94.85658.46-5.48112.45-40.20-3.38-126.57-225.6694.7663.98-13.7747.72-18.6622.3170.5032.5514.83-18.5938.2123.8425.19-1.97
---------------------------
---------------------------
111111111111101011111111101010101010.2610.2610.2610.2610.2610.2610.2610.2610.2610.26
---------------------------
Details

Keystats

Revenue and Growth

The GL Sciences Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the GL Sciences is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (M)INVENTORIES (B)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (B)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (B)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (B)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (B)UNREAL. GAINS/LOSSES (B)EQUITY (B)LIABILITIES (B)PROVISIONS (M)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (B)LONG-TERM DEBT PORTION (B)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (B)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                     
3.093.364.913.133.32.873.133.92.972.522.913.153.53.894.675.15.034.774.515.084.975.425.896.366.126.567.45
4.153.774.795.294.674.615.225.176.176.626.334.915.75.345.925.87.316.516.147.147.938.428.49.29.5611.112.25
000000000000000000000000780.04568.19495.75
3.483.112.783.343.93.863.43.514.094.384.13.613.233.453.352.863.23.433.673.744.75.565.967.067.9811.1812.45
8640344454795391366370495383351272395343424573530499.85416.39511.81240.54302.38144.79359.28390.36634.31703.61
10.8110.2812.8212.2112.6711.7312.1112.9513.7213.913.6911.9512.8213.0314.3614.3416.0615.214.7316.4717.8419.6920.422.9724.8330.0433.35
4.564.584.725.76.937.47.277.838.077.998.338.067.717.437.237.067.597.687.667.738.8710.2410.5312.714.6417.0317.07
0.370.430.421.180.690.610.720.741.091.20.760.630.760.710.750.831.081.531.11.261.771.231.041.561.992.513.38
000000000000000000000000000
2514818016620918416914410511393948980918490.75123.05131.33413.65369.11351.96483.74466.39496.01637.63
918700012240000000000000000000000
0.690.70.911.381.941.410.880.990.750.820.50.690.660.750.480.530.440.620.810.840.590.550.760.961.050.941.13
6.566.426.148.349.959.629.049.7310.0510.119.79.479.228.978.538.519.199.939.699.9611.6412.3912.6915.7118.1520.9722.22
17.3616.718.9520.5522.6221.3521.1522.6823.7724.0123.3921.4222.042222.8922.8425.2525.1424.4226.4429.4832.0833.0938.6842.9851.0155.57
                                                     
1.041.041.041.041.041.041.041.211.211.211.211.211.211.211.211.211.211.211.211.211.211.211.211.211.211.211.21
1.581.581.581.581.581.581.581.821.821.821.821.821.821.821.821.821.821.821.821.821.821.821.821.821.821.821.82
4.755.347.037.868.958.869.259.5710.3610.681110.610.5610.7811.2311.612.2312.6313.2314.3615.8317.5318.7620.723.0926.0828.84
0000-0.01-0-0.05-0.090.080.140.07-0.05-0.07-0.22-0.190.020.420.850.30.230.410.320.210.580.910.871.24
0000.07-0.34-0.37-0.24-0.25-0.07-0.15-0.33-0.44-0.38-0.36-0.34-0.24-0.190.040-00.170.04-0.090.090.290.431.05
7.387.969.6510.5611.2311.1111.5812.2713.413.6913.7713.1413.1413.2313.7314.4115.4816.5516.5617.6219.4320.9321.924.427.3130.434.15
2.141.812.062.592.722.192.382.22.752.892.412.042.252.082.362.212.822.592.192.652.963.423.033.323.914.083.98
583455411468327346455772375416402377406364400344366384.99395.82447.94535.69533.87565.81610.9726.64788.77836.27
1.580.582.831.350.60.60.510.631.060.830.580.390.820.530.750.791.120.70.891.251.371.451.231.71.962.512.45
0000000000000001.51.41.4300.821.120.790.941.471.511.832.32
1.373.090.831.052.412.472.061.281.361.812.041.892.642.392.730.820.770.591.690.350.420.490.530.710.651.111.02
5.675.936.125.456.065.615.414.895.545.945.444.76.115.366.235.656.475.75.165.526.416.696.297.818.7510.3110.61
3.722.120.51.011.791.551.232.262.071.651.671.911.171.520.890.821.190.60.30.70.951.491.642.6224.33.57
00150140135130130130225187136129129113113113102.3597.0297.0297.0297.0297.0297.0297.0297.02728.36
0.290.30.581.121.090.680.7810.570.440.370.390.360.570.610.40.280.350.580.550.340.320.320.410.60.720.45
42.421.092.133.022.362.143.42.762.322.222.431.662.221.621.331.571.050.981.341.381.92.063.122.695.124.75
9.678.367.227.579.087.977.558.298.38.267.667.137.777.587.856.988.046.746.146.867.798.598.3510.9311.4515.4315.36
17.0516.3216.8718.1320.319.0919.1320.5521.721.9521.4320.2720.9120.8121.5821.3923.5223.2922.724.4727.2329.5230.2535.3238.7645.8349.51
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of GL Sciences provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand GL Sciences's financial health and stability.

Assets

GL Sciences's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that GL Sciences must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of GL Sciences after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into GL Sciences's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (B)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (B)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (B)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (B)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (B)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
4.292.810.820.220.970.831.751.350.88-0.120.190.650.950.871.4111.112.062.663.422.763.9656.49
1.20.510.590.890.640.630.690.720.750.780.720.660.650.620.640.710.730.680.790.91.11.161.191.59
000000000000000000000000
-1.28-3.78-1.1-0.04-0.02-0.22-1.94-1.29-0.411.12-0.19-0.4-0.230.29-1.37-0.38-0.41-1.02-1.62-1.93-1.73-2.4-2.62-6.11
-3,7563898759-107273-466-149-33138303-7395222026-7919-83-305992412619
603847474339354665685951473933302115202022273135
0.772.780.81-0.170.030.140.650.730.340.230.140.210.180.230.210.690.060.410.690.811.020.711.41.58
0.45-0.080.41.131.481.520.040.631.181.921.030.831.471.810.711.351.341.741.752.092.232.743.691.99
-614-1,695-2,864-1,160-569-1,174-693-518-1,081-594-431-371-444-545-861-686-739-778-1,998-2,009-1,389-3,344-2,777-3,158
2.7-0.96-2.22-1.17-0.13-1.15-1.02-0.59-1.19-0.67-0.42-0.44-0.41-0.65-0.46-0.75-0.71-0.2-1.72-1.22-1.6-3.5-2.95-3.6
3.320.740.65-0.010.440.02-0.32-0.07-0.11-0.080.01-0.070.03-0.10.4-0.070.030.580.280.79-0.21-0.15-0.17-0.44
000000000000000000000000
-3.890.742.08-0.21-0.730.25-0.120.030.24-0.040.010.08-0.2-0.520.04-0.74-0.56-0.170.140.020.321.67-0.652.54
1.1400-0-0.180.5800-0.08-0.43-0.0300000-00000-00-0
-2.880.41.86-0.38-1.090.63-0.34-0.24-0.12-0.74-0.25-0.08-0.37-0.69-0.14-0.93-0.75-0.37-0.17-0.32-0.131.3-1.141.89
-14.00-68.00-88.00-33.00-41.00-38.00-21.00-27.00-30.00-27.00---13.00-19.00-20.00-27.00-15.00-15.00-24.00-26.00-39.00-53.00-87.00-132.00
-122-265-132-133-133-154-195-250-250-250-232-154-153-153-153-164-174-184-276-307-410-307-409-512
0.27-0.630.04-0.40.220.97-1.15-0.21-0.140.490.360.290.650.520.18-0.23-0.151.18-0.170.540.490.52-0.240.44
-165.7-1,776.7-2,463-29.1912.5344.5-654.4113.497.81,326.7594.6461.21,029.91,263.1-154.1665.61601.85960.14-248.5979.79844.6-600.87913.14-1,172.21
000000000000000000000000

GL Sciences stock margins

The GL Sciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of GL Sciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for GL Sciences.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the GL Sciences's sales revenue. A higher gross margin percentage indicates that the GL Sciences retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the GL Sciences's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the GL Sciences's total revenue generated. When comparing the revenue margin year over year, investors can gauge the GL Sciences's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the GL Sciences. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the GL Sciences's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

GL Sciences Margin History

GL Sciences Gross marginGL Sciences Profit marginGL Sciences EBIT marginGL Sciences Profit margin
202436.31 %15.38 %9.24 %
202334.67 %15.6 %9.05 %
202233.91 %14.51 %8.44 %
202133.47 %13.16 %7.73 %
202033.35 %10.64 %6.4 %
201935.3 %12.05 %8.09 %
201835.55 %10.54 %7.62 %
201735.03 %8.75 %6.41 %
201632.91 %5.16 %4.18 %
201533.32 %4.89 %3.49 %
201436.07 %7.09 %4.18 %
201335.35 %6.27 %3.14 %
201233.17 %5.72 %3.69 %
201133.07 %4.55 %2.29 %
201031.09 %1.78 %1.22 %
200928.95 %0.3 %-0.93 %
200829.31 %4.34 %3.09 %
200730.39 %6.33 %3.12 %
200632.41 %6.71 %5.9 %
200532.22 %6.4 %2.8 %

GL Sciences Stock Sales Revenue, EBIT, Earnings per Share

The GL Sciences earnings per share therefore indicates how much revenue GL Sciences has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue GL Sciences earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates GL Sciences's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of GL Sciences’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating GL Sciences's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

GL Sciences Revenue, EBIT and net profit per share

DateGL Sciences Sales per ShareGL Sciences EBIT per shareGL Sciences Earnings per Share
20243,620.76 undefined556.95 undefined334.38 undefined
20233,770.05 undefined588.14 undefined341.05 undefined
20223,228.11 undefined468.52 undefined272.45 undefined
20212,847.73 undefined374.89 undefined220 undefined
20202,488.37 undefined264.74 undefined159.21 undefined
20192,417.23 undefined291.32 undefined195.54 undefined
20182,235.76 undefined235.73 undefined170.28 undefined
20172,006.12 undefined175.56 undefined128.52 undefined
20161,803.09 undefined93.09 undefined75.42 undefined
20151,768.46 undefined86.5 undefined61.67 undefined
20141,857.9 undefined131.7 undefined77.7 undefined
20131,674 undefined105 undefined52.6 undefined
20121,650.9 undefined94.5 undefined61 undefined
20111,621.7 undefined73.8 undefined37.2 undefined
20101,567.9 undefined27.9 undefined19.1 undefined
20091,484 undefined4.45 undefined-13.82 undefined
20081,685.18 undefined73.18 undefined52 undefined
20071,725 undefined109.27 undefined53.82 undefined
20061,526 undefined102.36 undefined90 undefined
20051,665.6 undefined106.6 undefined46.6 undefined

GL Sciences business model

GL Sciences is one of the most popular companies on Eulerpool.com.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

GL Sciences Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

GL Sciences historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

GL Sciences shares outstanding

The number of shares was GL Sciences in 2023 — This indicates how many shares 10.26 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue GL Sciences earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates GL Sciences's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of GL Sciences’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating GL Sciences's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

GL Sciences stock splits

In GL Sciences's history, there have been no stock splits.

GL Sciences dividend history and estimates

In 2023, GL Sciences paid a dividend amounting to 60 JPY. Dividend means that GL Sciences distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for GL Sciences provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify GL Sciences’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating GL Sciences's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

GL Sciences Dividend History

DateGL Sciences Dividend
202470 undefined
202360 undefined
202245 undefined
202135 undefined
202030 undefined
201930 undefined
201830 undefined
201722 undefined
201618 undefined
201517 undefined
201416 undefined
201315 undefined
201215 undefined
201115 undefined
201015 undefined
200922.5 undefined
200822.5 undefined
200722.5 undefined
200620 undefined
200517.5 undefined

GL Sciences dividend payout ratio

In 2023, GL Sciences had a payout ratio of 17.09%. The payout ratio indicates the percentage of the company's profits that GL Sciences distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for GL Sciences represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for GL Sciences could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate GL Sciences's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

GL Sciences Payout Ratio History

DateGL Sciences Payout ratio
202416.5 %
202317.09 %
202216.52 %
202115.91 %
202018.84 %
201915.34 %
201817.62 %
201717.12 %
201623.86 %
201527.57 %
201420.59 %
201328.52 %
201224.59 %
201140.32 %
201078.53 %
2009-162.93 %
200843.27 %
200741.81 %
200622.22 %
200537.55 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for GL Sciences.

GL Sciences shareholders

%
Name
Stocks
Change
Date
7.61394 % GL Sciences Inc. Employees852,000-93,0003/31/2024
5.18320 % Shimadzu Corp580,00003/31/2024
4.52189 % Mori (Reiko)506,00003/31/2024
4.45219 % MUFG Bank, Ltd.498,2002007/22/2024
4.43253 % The Yamaguchi Bank, Ltd.496,00003/31/2024
3.96783 % The Minato Bank, Ltd.444,00003/31/2024
3.79803 % Tokyo Small and Medium Business Investment & Consultation Co., Ltd.425,00003/31/2024
3.57462 % WWF Japan400,00003/31/2024
3.01162 % YMC Company337,000-6,0003/31/2024
2.02770 % Nishikawa Keisoku Co Ltd226,900170,2006/30/2023
1
2
3

Most common questions regarding GL Sciences

What is the P/E ratio of GL Sciences 2024?

The GL Sciences P/E ratio is 8.42.

What is the P/S ratio of GL Sciences 2024?

The GL Sciences P/S ratio is 0.78.

What is the Quality Investing of GL Sciences?

The Quality Investing for GL Sciences is 7/10.

What is the revenue of GL Sciences 2024?

The GL Sciences revenue is 37.15 B JPY.

How high is the profit of GL Sciences 2024?

The GL Sciences profit is 3.43 B JPY.

What is the business model of GL Sciences

No history available for GL Sciences.

What is the GL Sciences dividend?

GL Sciences pays a dividend of 45 JPY distributed over payouts per year.

How often does GL Sciences pay dividends?

The dividend cannot currently be calculated for GL Sciences or the company does not pay out a dividend.

What is the GL Sciences ISIN?

The ISIN of GL Sciences is JP3385850007.

What is the GL Sciences ticker?

The ticker of GL Sciences is 7705.T.

How much dividend does GL Sciences pay?

Over the past 12 months, GL Sciences paid a dividend of 70 JPY . This corresponds to a dividend yield of about 2.48 %. For the coming 12 months, GL Sciences is expected to pay a dividend of 70 JPY.

What is the dividend yield of GL Sciences?

The current dividend yield of GL Sciences is 2.48 %.

When does GL Sciences pay dividends?

GL Sciences pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of GL Sciences?

GL Sciences paid dividends every year for the past 20 years.

What is the dividend of GL Sciences?

For the upcoming 12 months, dividends amounting to 70 JPY are expected. This corresponds to a dividend yield of 2.48 %.

In which sector is GL Sciences located?

GL Sciences is assigned to the 'Information technology' sector.

Wann musste ich die Aktien von GL Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of GL Sciences from 6/1/2024 amounting to 70 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.

When did GL Sciences pay the last dividend?

The last dividend was paid out on 6/1/2024.

What was the dividend of GL Sciences in the year 2023?

In the year 2023, GL Sciences distributed 60 JPY as dividends.

In which currency does GL Sciences pay out the dividend?

The dividends of GL Sciences are distributed in JPY.

All fundamentals about GL Sciences

Our stock analysis for GL Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of GL Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.